Gold nanoparticle-assisted delivery of small, highly structured RNA into the nuclei of human cells

Biochemical and Biophysical Research Communications

Volumn 416, Issue 1-2, 2011, Pages 178-183

  Ryou, Sang Mi ^a   Kim, Jong Myung ^b   Yeom, Ji Hyun ^b   Hyun, Seogang ^b   Kim, Sudeok ^b   Han, Min Su ^b   Kim, Si Wouk ^c   Bae, Jeehyeon ^a   Rhee, Sangmyung ^b   Lee, Kangseok ^b  

^a CHA University   (South Korea)

^b Chung Ang University   (South Korea)

^c Chosun University   (South Korea)

Author keywords

Catenin; Gold nanoparticle assisted gene delivery system (AuNP GDS); NF B p50; RNA aptamer

Indexed keywords

APTAMER; BETA CATENIN; CYCLIN D; GOLD NANOPARTICLE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOSOME; MESSENGER RNA; PROTEIN P50; RNA; SINGLE STRANDED DNA FUNCTIONALIZED GOLD NANOPARTICLE; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; GENE TARGETING; HUMAN; HUMAN CELL; LIPOSOMAL GENE DELIVERY SYSTEM; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN BINDING; RNA STRUCTURE; WESTERN BLOTTING;

APOPTOSIS; APTAMERS, NUCLEOTIDE; BETA CATENIN; CELL NUCLEUS; GOLD; HEP G2 CELLS; HUMANS; METAL NANOPARTICLES; NF-KAPPA B P50 SUBUNIT; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 83055185686     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.020     Document Type: Article

References (47)

1. Ellington A.D., Szostak J.W. In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
2. Ellington A.D., Szostak J.W. Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures. Nature 1992, 355:850-852.
3. Ulrich H. DNA and RNA aptamers as modulators of protein function. Med. Chem. 2005, 1:199-208.
4. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
5. Dausse E., Da Rocha Gomes S., Toulme J.J. Aptamers: a new class of oligonucleotides in the drug discovery pipeline?. Curr. Opin. Pharmacol. 2009, 9:602-607.
6. Thiel K.W., Giangrande P.H. Therapeutic applications of DNA and RNA aptamers. Oligonucleotides 2009, 19:209-222.
7. Farokhzad O.C., Jon S., Khademhosseini A., Tran T.N., Lavan D.A., Langer R. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 2004, 64:7668-7672.
8. Que-Gewirth N.S., Sullenger B.A. Gene therapy progress and prospects: RNA aptamers. Gene Ther. 2007, 14:283-291.
9. Akiyama H., Kachi S., Silva R.L., Umeda N., Hackett S.F., McCauley D., McCauley T., Zoltoski A., Epstein D.M., Campochiaro P.A. Intraocular injection of an aptamer that binds PDGF-B: a potential treatment for proliferative retinopathies. J. Cell. Physiol. 2006, 207:407-412.
10. Mi J., Zhang X., Rabbani Z.N., Liu Y., Su Z., Vujaskovic Z., Kontos C.D., Sullenger B.A., Clary B.M. H1 RNA polymerase III promoter-driven expression of an RNA aptamer leads to high-level inhibition of intracellular protein activity. Nucleic Acids Res. 2006, 34:3577-3584.
11. Sullenger B.A., Gallardo H.F., Ungers G.E., Gilboa E. Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication. Cell 1990, 63:601-608.
12. Tekade R.K., Kumar P.V., Jain N.K. Dendrimers in oncology: an expanding horizon. Chem. Rev. 2009, 109:49-87.
13. Guo X., Szoka F.C. Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Acc. Chem. Res. 2003, 36:335-341.
14. Mintzer M.A., Simanek E.E. Nonviral vectors for gene delivery. Chem. Rev. 2009, 109:259-302.
15. Bellocq N.C., Pun S.H., Jensen G.S., Davis M.E. Transferrin-containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery. Bioconjug. Chem. 2003, 14:1122-1132.
16. Kursa M., Walker G.F., Roessler V., Ogris M., Roedl W., Kircheis R., Wagner E. Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. Bioconjug. Chem. 2003, 14:222-231.
17. Qian Z.M., Li H., Sun H., Ho K. Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. Pharmacol. Rev. 2002, 54:561-587.
18. Robbins P.D., Ghivizzani S.C. Viral vectors for gene therapy. Pharmacol. Ther. 1998, 80:35-47.
19. Seow Y., Wood M.J. Biological gene delivery vehicles: beyond viral vectors. Mol. Ther. 2009, 17:767-777.
20. Daniel M.C., Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem. Rev. 2004, 104:293-346.
21. Rosi N.L., Giljohann D.A., Thaxton C.S., Lytton-Jean A.K., Han M.S., Mirkin C.A. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science 2006, 312:1027-1030.
22. Kim J.H., Jang H.H., Ryou S.M., Kim S., Bae J., Lee K., Han M.S. A functionalized gold nanoparticles-assisted universal carrier for antisense DNA. Chem. Commun. (Camb.) 2010, 46:4151-4153.
23. Kim J.H., Yeom J.H., Ko J.J., Han M.S., Lee K., Na S.Y., Bae J. Effective delivery of anti-miRNA DNA oligonucleotides by functionalized gold nanoparticles. J. Biotechnol. 2011, 155:287-292.
24. Ryou S.M., Kim S., Jang H.H., Kim J.H., Yeom J.H., Eom M.S., Bae J., Han M.S., Lee K. Delivery of shRNA using gold nanoparticle-DNA oligonucleotide conjugates as a universal carrier. Biochem. Biophys. Res. Commun. 2010, 398:542-546.
25. S.M. Ryou, M. Park, J.M. Kim, C.O. Jeon, C.H. Yun, S.H. Han, S.W. Kim, Y. Lee, S. Kim, M.S. Han, J. Bae, K. Lee, Inhibition of xenograft tumor growth in mice by gold nanoparticle-assisted delivery of short hairpin RNAs against Mcl-1L, J. Biotechnol. (2011).
26. Kim D.W., Kim J.H., Park M., Yeom J.H., Go H., Kim S., Han M.S., Lee K., Bae J. Modulation of biological processes in the nucleus by delivery of DNA oligonucleotides conjugated with gold nanoparticles. Biomaterials 2011, 32:2593-2604.
27. Choi Y.S., Hur J., Lee H.K., Jeong S. The RNA aptamer disrupts protein-protein interaction between beta-catenin and nuclear factor-kappaB p50 and regulates the expression of C-reactive protein. FEBS Lett. 2009, 583:1415-1421.
28. Kim S.J., Kim M.Y., Lee J.H., You J.C., Jeong S. Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein. Biochem. Biophys. Res. Commun. 2002, 291:925-931.
29. Lee H.K., Choi Y.S., Park Y.A., Jeong S. Modulation of oncogenic transcription and alternative splicing by beta-catenin and an RNA aptamer in colon cancer cells. Cancer Res. 2006, 66:10560-10566.
30. Choi Y.S., Hur J., Jeong S. Beta-catenin binds to the downstream region and regulates the expression C-reactive protein gene. Nucleic Acids Res. 2007, 35:5511-5519.
31. Dihlmann S., von Knebel Doeberitz M. Wnt/beta-catenin-pathway as a molecular target for future anti-cancer therapeutics. Int. J. Cancer 2005, 113:515-524.
32. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.
33. Korinek V., Barker N., Morin P.J., van Wichen D., de Weger R., Kinzler K.W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997, 275:1784-1787.
34. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
35. Behrens J., Jerchow B.A., Wurtele M., Grimm J., Asbrand C., Wirtz R., Kuhl M., Wedlich D., Birchmeier W. Functional interaction of an axin homolog, conductin, with beta-catenin, APC, and GSK3beta. Science 1998, 280:596-599.
36. Polakis P. Wnt signaling and cancer. Genes Dev. 2000, 14:1837-1851.
37. Crawford H.C., Fingleton B.M., Rudolph-Owen L.A., Goss K.J., Rubinfeld B., Polakis P., Matrisian L.M. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 1999, 18:2883-2891.
38. Deng J., Miller S.A., Wang H.Y., Xia W., Wen Y., Zhou B.P., Li Y., Lin S.Y., Hung M.C. Beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell. 2002, 2:323-334.
39. Sun J., Hobert M.E., Duan Y., Rao A.S., He T.C., Chang E.B., Madara J.L. Crosstalk between NF-kappaB and beta-catenin pathways in bacterial-colonized intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2005, 289:G129-G137.
40. Cha-Molstad H., Agrawal A., Zhang D., Samols D., Kushner I. The Rel family member P50 mediates cytokine-induced C-reactive protein expression by a novel mechanism. J. Immunol. 2000, 165:4592-4597.
41. Agrawal A., Cha-Molstad H., Samols D., Kushner I. Transactivation of C-reactive protein by IL-6 requires synergistic interaction of CCAAT/enhancer binding protein beta (C/EBP beta) and Rel p50. J. Immunol. 2001, 166:2378-2384.
42. Waterman M.L. Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev. 2004, 23:41-52.
43. Rubinfeld B., Robbins P., El-Gamil M., Albert I., Porfiri E., Polakis P. Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 1997, 275:1790-1792.
44. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., van der Horn K., Batlle E., Coudreuse D., Haramis A.P., Tjon-Pon-Fong M., Moerer P., van den Born M., Soete G., Pals S., Eilers M., Medema R., Clevers H. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111:241-250.
45. Hulit J., Wang C., Li Z., Albanese C., Rao M., Di Vizio D., Shah S., Byers S.W., Mahmood R., Augenlicht L.H., Russell R., Pestell R.G. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol. Cell. Biol. 2004, 24:7598-7611.
46. Lebruska L.L., Maher L.J. Selection and characterization of an RNA decoy for transcription factor NF-kappa B. Biochemistry 1999, 38:3168-3174.
47. Cassiday L.A., Maher L.J. Yeast genetic selections to optimize RNA decoys for transcription factor NF-kappa B. Proc. Natl. Acad. Sci. USA 2003, 100:3930-3935.